Sacubitril - Valsartan should be the starting treatment in HFrEF patients - Rebuttal PRO
28 August 2018 (11:55 - 12:00)
Organised by:
About the speaker
Baylor University Medical Center, Dallas (United States of America)
7 More presentations in this session
Professor G. Filippatos (Athens, GR)
Professor M. Packer (Dallas, US)
Professor A. Voors (Groningen, NL)
Professor A. Voors (Groningen, NL)
Access the full session
The Event
ESC Congress 2018
28 August 2018
11:55 CET
